drug
Testim
Marketedupdated 5mo agoby Par Pharmaceutical Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 8- drugtestosterone54 co-mentions · 51 sources
- drugVogelxo54 co-mentions · 51 sources
- drugBio T54 co-mentions · 51 sources
- tagRecall45 co-mentions · 44 sources
- tagApproval12 co-mentions · 6 sources
- drugtriamcinolone acetonide Rising10 co-mentions · 10 sources
- drugTRIAMCINOLONE ACETONIDE10 co-mentions · 10 sources
- drugtriamcinolone acetonide ER10 co-mentions · 10 sources
all catalysts(0)
nothing on the calendar yet
Trials studying Testim
- phase2Working Out M0 Bipolar Androgen Therapy
- phase2Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
- phase352 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
- phase2Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)
- phase2Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
- phase4Ambulatory Blood Pressure Monitoring (ABPM) Study in Hypogonadal Men
- phase2Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
- phase2Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer
Patent cliff
source: FDA Orange Bookfirst barrier falls
Oct 12, 2026
16 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (38)
- Mar 17, 2034method-of-use (U-1616)US 11090312
- Mar 17, 2034method-of-use (U-4367)US 11744838
- Feb 11, 2034formulationUS 8785426
- Feb 11, 2034formulationUS 8785426
- Feb 11, 2034formulationUS 9295675
- Feb 11, 2034formulationUS 9295675
- Feb 11, 2034formulationUS 9662340
- Feb 11, 2034formulationUS 9662340
- Sep 27, 2027method-of-use (U-1390)US 84359441.0y
- Feb 26, 2027method-of-use (U-1386)US 8419307153d
- Feb 26, 2027formulationUS 8807861153d
- Feb 26, 2027method-of-use (U-1390)US 9289586153d
- Oct 12, 2026formulationUS 846613616d
- Oct 12, 2026formulationUS 846613616d
- Oct 12, 2026formulationUS 846613616d
- Oct 12, 2026method-of-use (U-1103)US 846613716d
- Oct 12, 2026method-of-use (U-1103)US 846613716d
- Oct 12, 2026method-of-use (U-1103)US 846613716d
- Oct 12, 2026method-of-use (U-1103)US 846613816d
- Oct 12, 2026method-of-use (U-1103)US 846613816d
- Oct 12, 2026method-of-use (U-1103)US 846613816d
- Oct 12, 2026formulationUS 848692516d
- Oct 12, 2026formulationUS 848692516d
- Oct 12, 2026formulationUS 848692516d
- Oct 12, 2026formulationUS 872905716d
- Oct 12, 2026formulationUS 872905716d
- Oct 12, 2026formulationUS 872905716d
- Oct 12, 2026method-of-use (U-1103)US 874188116d
- Oct 12, 2026method-of-use (U-1103)US 874188116d
- Oct 12, 2026method-of-use (U-1103)US 874188116d
- Oct 12, 2026formulationUS 875407016d
- Oct 12, 2026formulationUS 875407016d
- Oct 12, 2026formulationUS 875407016d
- Oct 12, 2026formulationUS 875932916d
- Oct 12, 2026formulationUS 875932916d
- Oct 12, 2026formulationUS 875932916d
- Jun 2, 2026method-of-use (U-1390)US 8993520
- Jun 2, 2026method-of-use (U-1390)US 9180194
News(10)
- Opinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDATwo former FDA commissioners: Heidi Overton is the right pick in a difficult moment.stat · 3d ago
- Opinion: More young men are coming to me for plastic surgery. The way I think about them has changed“The young men in my clinic are responding rationally to a system that was designed for profit,” writes plastic surgeon Kavitha Ranganathan.stat · 7d ago
- This Week at FDA: Overton nomination hearing, FDA’s hiring challenges, and moreThis week, a Senate committee scheduled a hearing for President Trump’s nominee to lead FDA, new reporting sheds light on the agency’s hiring challenges, and the agency held two meetings to conside…raps · 8d ago
- Disabled workers at greater risk of losing health insuranceAn organ transplant first, new details on ADA conference controversy, and more health news from Morning Roundsstat · 21d ago
- A new, separate outbreak of the diarrhea-causing parasiteA win for peptide proponents, autism advisory committees clash, and more health news from Morning Roundsstat · 2mo ago
- Expect a clash at today’s FDA peptide panelThe service members who refused the Covid vaccine, the fastest-growing Ebola outbreak in history, and other health news from Morning Roundsstat · 2mo ago
- Opinion: Good riddance to bundled ‘global’ maternal care billingNew maternal billing codes should create a transparent system where both patients and clinicians can thrive, ACOG writes.stat · 2mo ago
- Opinion: New billing codes likely to raise maternity care costs“This change is likely to lead to only modest increases in total medical expenses. However, it coincides with many other factors raising health insurance premiums,” writes Jeff Levin-Scherz.stat · 2mo ago
- Job dissatisfaction and health care access uncertainty grows in the U.S., new study findsWhat Hawaii's wildfires can teach the nation about health recovery, 4.5 million people disenrolled from SNAP, and more health newsstat · 2mo ago
- Opinion: STAT+: I’m a cardiologist. I’m not sure the new cholesterol drug enlicitide is a game-changer“In truth, I don’t anticipate prescribing patterns changing immediately,” cardiologist Vishal Khetpal writes of the new cholesterol drug Lipfendra.stat · 2mo ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that